Pharmageek
Vaccine ready is the theme of the National Minority Health Month in April, 2021. This
initiative aims to educate the public on health problems facing minority populations
in the USA. The vaccine theme has been chosen because, paradoxically, although minority
populations have been disproportionately impacted by COVID-19, they are also reported
to be the least likely to be vaccinated. Barriers against vaccination among minority
populations have been widely reported, including low confidence in the vaccine, poor
access, and distrust of the health system.
Lire l'article complet sur : www.thelancet.com
Pharmaceutical manufacturers and the US Centers for Disease Control and Prevention
rely on mobile phone apps and adverse event reporting websites as the primary means
of active surveillance from patients for COVID-19 vaccines.1 However, digital tools
for side-effect surveillance emphasise data collection over providing user feedback,
and public misperceptions might influence what is reported and the causal attributions.
Preliminary evidence shows that traditional fact-checking approaches to side-effect
misinformation can backfire by establishing unsound causal connections; when submitted
to health authorities, plausible reports of biological harm might be dismissed if
they are tinged with misperceptions.
Lire l'article complet sur : www.thelancet.com
In patients with COVID-19, artificial intelligence based on chest x-rays had better
prognostic performance than clinical data or radiologist-derived severity scores.
Using artificial intelligence, chest x-rays can augment clinical data in predicting
the risk of progression to critical illness in patients with COVID-19.
Lire l'article complet sur : www.thelancet.com
Paris, le mardi 20 avril 2021 - « Messieurs les Français, tirez les premiers ». Lundi 19 avril, la France est devenue le premier pays européen à adopter le modèle de certification électronique des tests de dépistage et d’attestation de vaccination contre la Covid-19.
Mis en œuvre par le biais de de [...]
Lire l'article complet sur : www.jim.fr